The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
about
Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studiesIndependent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: a meta-analysis.Cardiovascular consequences of obese and nonobese obstructive sleep apnea.Human adipocytes secrete mineralocorticoid-releasing factors.Molecular determinants of the cardiometabolic phenotype.Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative reviewUpregulation of ERK1/2-eNOS via AT2 receptors decreases the contractile response to angiotensin II in resistance mesenteric arteries from obese rats.DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women.Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation.Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.Obesity-induced hypertension: interaction of neurohumoral and renal mechanismsBlood Pressure Control at Rest and during Exercise in Obese Children and AdultsA brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activityBeta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulationHigh Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.The heart in obesity-hypertension.Increased incidence of diuretic use in critically ill obese patients.Antihypertensive treatment in patients with class 3 obesity.The Role of Aldosterone in Obesity-Related Hypertension.Measures of Body Size and Composition and Risk of Incident Atrial Fibrillation in Older People: The Cardiovascular Health Study.Atrial natriuretic peptide induces postprandial lipid oxidation in humansResistin, adiponectin, and risk of heart failure the Framingham offspring studyIncidence, Predictors, and Impact of Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting in Military Veterans.Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.Catheter Ablation of Atrial Fibrillation in Overweight and Obese Patients.Body Mass Index, Quality of Life, and Catheter Ablation in Patients with Atrial Fibrillation.Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implicationsFactors associated with the prevalence of hypertension in the southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study.Reduction of plasma aldosterone and arterial stiffness in obese pre- and stage1 hypertensive subjects after aerobic exercise.Validation of an integrative mathematical model of dehydration and rehydration in virtual humans.Hypertension: physiology and pathophysiology.Comparative analysis of plasma leptin levels in both genders of patients with essential hypertension and healthy subjects.The adipose tissue and the involvement of the renin-angiotensin-aldosterone system in cardiometabolic syndrome.Dynamic Relation of Changes in Weight and Indices of Fat Distribution With Cardiac Structure and Function: The Dallas Heart Study.[The role of aldosterone in hypertension].Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension.Association of body mass index with glomerular filtration rate in Japanese: a cross-sectional study in work-site population.Association between obesity and trastuzumab-related cardiac toxicity in elderly patients with breast cancer.Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.
P2860
Q30235956-97DAC1A4-16B4-46FA-A547-B83DF63E9B10Q30301249-656683AA-6C58-4768-8D6C-D8A2A27C4F4EQ33582266-ED94C3D5-16AF-4E2C-A157-C469C04C76ADQ33715978-2B0F54E6-3AA9-49DF-8256-F882E7563450Q33921392-F43B4B6D-19C5-4E71-93BE-9F8E402E6DA1Q34018585-860676FA-46BB-4CF9-92B5-ECB2E89D6B01Q34110231-606E01F8-F10A-4456-A0BB-E8DE089EC79BQ34139451-979F9F59-B9D1-454C-A0BD-98AA9793101DQ34714245-83C41974-2611-4DD6-9083-B9B037A89AABQ35021968-B92577A6-6D1B-4B2B-A19C-B54002839C11Q35108463-5B6AF886-EBBF-40A9-B829-1099790509AEQ35186358-4F0FE266-04A0-4809-8D40-2DE3DFD445C1Q35991051-ECE924C5-CD67-415F-B20D-D617E0333776Q36115561-61ECA2AB-5494-40B6-9097-4DD3FC3FEC33Q36131187-39915072-AB0C-4B9D-887C-3D798C892563Q36208883-129D82A8-BCFB-4CBB-991C-25456D0D8E9DQ36216822-F2C1DD94-36BA-4A21-9230-8069A69E6CD1Q36224448-1F13A494-F7A9-4F66-91EB-4030E3297028Q36328092-8675FCC9-6991-409A-9234-C949771BE17FQ36950174-9120A049-7EA3-4AC8-80DF-4B6E236F4843Q36952713-CEB9C256-11C2-4082-B046-7F66B0BBB289Q36975436-E15A5A0A-718D-4B9B-BC37-C78DFABC438CQ37178491-43CAA701-3839-4836-998B-0B6D14687CC4Q37344558-B3EC2E6A-70E4-4533-B68F-A8F918CF28B9Q37362676-F409976C-F9DD-4ABE-B096-AAADDE40122AQ37495903-AA506A1B-1E4C-4D92-950B-DD3F4168EC6CQ37496083-F067F47F-E5AA-47B5-AADA-81BA79965E13Q37518344-94569F5B-C0F5-478C-AF22-17F209F102E0Q37656597-BB52ABC8-6E5E-4AC9-9D8F-D7C6BFC3B781Q37700285-639A85A6-63E3-4143-956E-C0EE3AD99BDBQ37710971-2CE32E3F-16C6-442C-90D9-C1C6D7661CC8Q38110492-DE4CAACD-0111-47AA-AEE8-06F1241E449AQ38342212-C115459D-B9FE-4A79-B3C8-25B6192E4D59Q38979226-2A26B9F9-01A4-4A6E-9FA6-0C8ACE3B731EQ41627374-462B02E7-5B99-4D66-BF6B-CA4ACD0A084CQ43137773-AC6ED873-94EC-4FE2-93FA-4FA3F8C1963CQ43193916-9AAC6FE6-6198-46A5-BBFD-562C2D3EC4B5Q44451538-613C66A5-3596-4DCF-A44F-3E908BF3DE33Q45374763-A57D6588-3163-4EAF-A4C8-283E0AC56EDBQ46205392-2835EB0A-C4CD-494E-922A-9A297F42E59A
P2860
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
@ast
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
@en
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
@nl
type
label
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
@ast
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
@en
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
@nl
prefLabel
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
@ast
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
@en
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
@nl
P356
P1476
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
@en
P2093
P2888
P356
10.1007/S001090000144
P577
2001-01-01T00:00:00Z
P6179
1038595464